HRSA-21-080: Emerging Issues in Maternal and Child Health
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants of up to $250,000 to the applicants described in the notice. It expected to make about 6 awards worth $1.5 million in total. Applications closed on April 9, 2021.
From the official notice on Grants.gov, last changed January 8, 2021. Checked November 7, 2026.
- Award ceiling$250,000
- Total funding$1.5 million
- Expected awards6
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | January 8, 2021 |
|---|---|
| Deadline | April 9, 2021 |
| Archived by Grants.gov | June 8, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. § 450b) is eligible to apply. For your reference, see 42 CFR § 51a.3(a). Domestic faith-based and community-based organizations are also eligible to apply. For your reference, see 45 CFR part 87.
Is this a realistic fit?
- Past Special Projects of Regional and National Significance awards averaged $1.6 million; this notice allows up to $250,000 per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Emerging Issues in Maternal and Child Health Program. The purpose of this program is to strengthen the capacities of state- and/or local-level organizations to respond to emerging public health issues affecting maternal and child health (MCH) populations. This funding opportunity is a mechanism to support capacity-strengthening activities that will improve state- and/or local-level organizations’ abilities to address emerging issues that threaten the health and well-being of MCH populations in an effective, timely manner. For the purposes of this NOFO, MCH populations include the following groups: women, children (birth to 21), children with special health care needs (CSHCN), adolescents, and families. Recipients will implement a set of activities under at least one of the three capacity-strengthening areas below (See Section IV.2 for details) and through these activities address an emerging issue specific to their state or local community. Capacity Areas: 1) Data and Informational Systems 2) Workforce Development 3) Strategic Partnerships “Emerging issues” refers to issues that affect MCH populations at an increased rate, for which there is new knowledge or an increased level of awareness of, or there are new approaches to solving the issue. The challenge is that these issues are difficult to anticipate and thus difficult for which to have funds set aside. Through this program, the HRSA Maternal and Child Health Bureau (MCHB) aims to increase the ability of states and local communities to anticipate, prepare, and execute timely responses to emerging issues to reduce their negative impact on MCH populations. You will select an emerging issue specific to the needs of your state or local community. Examples of emerging issues include, but are not limited to, increasing rates of opioid and other substance use disorders, emergent environmental health threats, persistent or increasing disparities in maternal mortality, inadequate availability of and access to behavioral health services, disparities in access to health services for CSHCN, and declining immunization coverage. Successful projects will address an emerging issue that affects MCH populations and has reliable, current data to support it. In November 2020, MCHB released summaries of Title V state needs assessments.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-21-080 still open?
No. It closed on April 9, 2021. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Emerging Issues in Maternal and Child Health?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Emerging Issues in Maternal and Child Health?
Closed April 9, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $250,000 each. About $1.5 million in total across about 6 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)